Insider Trading History of Fowler Neal Franklin

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Fowler Neal Franklin since 2015. This trader's CIK number is 1493692. At the time of last reporting, Fowler Neal Franklin was the Director of Emergent Biosolutions Inc.. (stock ticker symbol EBS). Also see all insider trading activities at Emergent Biosolutions Inc..

Note that in the past Fowler Neal Franklin also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Liquidia Corp (LQDA) by Fowler Neal Franklin

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 LQDA 0 $0 0 $0 62,885 $116,337

Yearly summary of insider trading at Pozen Inc /nc (POZN) by Fowler Neal Franklin

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 POZN 0 $0 0 $0 45,804 $225,035

Yearly summary of insider trading at Emergent Biosolutions Inc. (EBS) by Fowler Neal Franklin

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 EBS 0 $0 35,000 $204,050 0 $0


Insider trading activities at 3 companies by Fowler Neal Franklin:

1. Liquidia Corp (LQDA)

2. Pozen Inc /nc (POZN)

3. Emergent Biosolutions Inc. (EBS)

Table 1. Insider trading of Liquidia Corp (LQDA) by Fowler Neal Franklin

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-11-19 LQDA Option Ex 62,885 1.85 116,337

Table 2. Insider trading of Pozen Inc /nc (POZN) by Fowler Neal Franklin

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-07-28 POZN Option Ex 45,804 4.91 225,035

Table 3. Insider trading of Emergent Biosolutions Inc. (EBS) by Fowler Neal Franklin

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-12 EBS Sale 35,000 5.83 204,050

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fowler Neal Franklin (Director of Emergent Biosolutions Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.